Factoring in acquisition interest for Consumer Healthcare
17/01/22 -"Moreover, with the possible monetisation of Consumer Healthcare, the firm should have sizeable resources at its disposal to expedite mega-transformation initiatives. As a result, we have removed the ..."
Pages
68
Language
English
Published on
17/01/22
You may also be interested by these reports :
27/10/26
The Q3 results were ahead of the street’s expectations, as generic erosion of a major heart failure drug was more than compensated for by robust ...
26/10/26
A guidance upgrade on top of the modest outlook uplift in July 2026 reflects UCB’s habit of making modest promises and then delivering otherwise. ...
22/10/26
The Q3 sales were ahead of the street’s expectations, driven by healthy growth across both segments. The beat, though, received support from a ...
22/10/26
Ipsen reported a robust Q3, resulting in an upgraded 2026 guidance. While we may revise our estimates upwards, we do not anticipate a significant ...